Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 7 | 2026 | 1041 | 1.390 |
Why?
|
| Parabiosis | 2 | 2026 | 27 | 1.130 |
Why?
|
| Blood-Brain Barrier | 2 | 2026 | 108 | 1.070 |
Why?
|
| Microvessels | 2 | 2026 | 99 | 0.950 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2026 | 51 | 0.940 |
Why?
|
| Cellular Senescence | 3 | 2025 | 149 | 0.920 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2026 | 311 | 0.860 |
Why?
|
| Heart | 1 | 2025 | 232 | 0.820 |
Why?
|
| Brain | 7 | 2025 | 774 | 0.800 |
Why?
|
| Transcriptome | 4 | 2025 | 244 | 0.690 |
Why?
|
| Cognitive Dysfunction | 3 | 2023 | 271 | 0.450 |
Why?
|
| Mice | 10 | 2026 | 4870 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 5 | 2026 | 1684 | 0.410 |
Why?
|
| Cerebrovascular Circulation | 5 | 2023 | 227 | 0.390 |
Why?
|
| Animals | 14 | 2026 | 10806 | 0.370 |
Why?
|
| Glioblastoma | 2 | 2022 | 110 | 0.300 |
Why?
|
| Brain Neoplasms | 2 | 2022 | 315 | 0.260 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 479 | 0.240 |
Why?
|
| Rejuvenation | 1 | 2026 | 43 | 0.240 |
Why?
|
| Intracranial Hemorrhages | 1 | 2025 | 32 | 0.230 |
Why?
|
| Thrombectomy | 1 | 2025 | 30 | 0.230 |
Why?
|
| Time-to-Treatment | 1 | 2025 | 33 | 0.220 |
Why?
|
| Endovascular Procedures | 1 | 2025 | 77 | 0.210 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 18 | 0.200 |
Why?
|
| Hyperhomocysteinemia | 1 | 2023 | 29 | 0.200 |
Why?
|
| Endothelium, Vascular | 1 | 2026 | 347 | 0.200 |
Why?
|
| Dementia, Vascular | 1 | 2023 | 57 | 0.180 |
Why?
|
| Exoribonucleases | 1 | 2022 | 20 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 847 | 0.180 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 53 | 0.180 |
Why?
|
| Neuroblastoma | 1 | 2022 | 59 | 0.170 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 225 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 90 | 0.170 |
Why?
|
| Cognition | 1 | 2024 | 331 | 0.170 |
Why?
|
| Brain Stem Neoplasms | 1 | 2020 | 12 | 0.160 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2020 | 23 | 0.160 |
Why?
|
| Sirolimus | 1 | 2021 | 76 | 0.160 |
Why?
|
| Male | 2 | 2026 | 14126 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 346 | 0.160 |
Why?
|
| Motor Neurons | 1 | 2020 | 44 | 0.150 |
Why?
|
| Signal Transduction | 1 | 2026 | 1502 | 0.150 |
Why?
|
| Benzenesulfonates | 1 | 2019 | 18 | 0.150 |
Why?
|
| Imines | 1 | 2019 | 21 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2019 | 36 | 0.150 |
Why?
|
| Glioma | 1 | 2020 | 123 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 88 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 276 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 128 | 0.140 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 136 | 0.140 |
Why?
|
| Neurovascular Coupling | 1 | 2020 | 154 | 0.140 |
Why?
|
| Spinal Cord | 1 | 2020 | 215 | 0.130 |
Why?
|
| Hippocampus | 1 | 2019 | 198 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 336 | 0.130 |
Why?
|
| Naphthalimides | 1 | 2016 | 1 | 0.130 |
Why?
|
| Organophosphonates | 1 | 2016 | 7 | 0.120 |
Why?
|
| Herpesvirus 3, Human | 1 | 2016 | 12 | 0.120 |
Why?
|
| Humans | 9 | 2025 | 29211 | 0.090 |
Why?
|
| Nitrogen Oxides | 2 | 2022 | 41 | 0.090 |
Why?
|
| Time Factors | 2 | 2025 | 1619 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2022 | 828 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 1524 | 0.060 |
Why?
|
| Incidence | 1 | 2025 | 581 | 0.050 |
Why?
|
| Methionine | 1 | 2023 | 38 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 144 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 130 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 4 | 0.050 |
Why?
|
| Reperfusion | 1 | 2022 | 7 | 0.050 |
Why?
|
| Uracil | 1 | 2022 | 10 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 201 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2022 | 41 | 0.040 |
Why?
|
| Gray Matter | 1 | 2022 | 24 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 740 | 0.040 |
Why?
|
| Superoxides | 1 | 2022 | 62 | 0.040 |
Why?
|
| Diet | 1 | 2023 | 243 | 0.040 |
Why?
|
| Ischemia | 1 | 2022 | 83 | 0.040 |
Why?
|
| Neurosciences | 1 | 2020 | 10 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 646 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 790 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 378 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 130 | 0.040 |
Why?
|
| Antioxidants | 1 | 2022 | 228 | 0.040 |
Why?
|
| Microcirculation | 1 | 2020 | 113 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2022 | 669 | 0.040 |
Why?
|
| Chickens | 1 | 2019 | 62 | 0.040 |
Why?
|
| Inositol | 1 | 2019 | 6 | 0.040 |
Why?
|
| Perfusion Imaging | 1 | 2019 | 10 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 377 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2019 | 44 | 0.040 |
Why?
|
| Choline | 1 | 2019 | 20 | 0.040 |
Why?
|
| Creatine | 1 | 2019 | 32 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 111 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2019 | 52 | 0.040 |
Why?
|
| Oxygen | 1 | 2020 | 238 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2025 | 2442 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 80 | 0.040 |
Why?
|
| Contrast Media | 1 | 2019 | 96 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 168 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 157 | 0.030 |
Why?
|
| Obesity | 1 | 2024 | 705 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 554 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 1595 | 0.030 |
Why?
|
| Oklahoma | 1 | 2020 | 1063 | 0.030 |
Why?
|
| Cytostatic Agents | 1 | 2016 | 2 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 17 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 34 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2016 | 212 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 247 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1362 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2016 | 114 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 705 | 0.030 |
Why?
|
| Child | 1 | 2020 | 2354 | 0.030 |
Why?
|
| Aged | 1 | 2023 | 5648 | 0.020 |
Why?
|